← All trials
NCT06004115
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 8, 2023
- Primary completion
- Apr 30, 2027
- Completion date
- Apr 30, 2027
- First posted
- Aug 22, 2023
- Last posted
- Nov 15, 2023
- Enrollment
- 165
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Laureate Institute for Brain ResearchLead sponsor
- National Institute of Mental Health (NIMH)Collaborator
- Laureate Institute for Brain ResearchOverall official - principal investigator
- California Institute of TechnologyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.